1BD logo

Bio-Works Technologies DB:1BD Stock Report

Last Price

€0.059

Market Cap

€6.1m

7D

18.6%

1Y

-90.1%

Updated

05 Jan, 2025

Data

Company Financials

Bio-Works Technologies AB (publ)

DB:1BD Stock Report

Market Cap: €6.1m

1BD Stock Overview

A biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. More details

1BD fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Bio-Works Technologies AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bio-Works Technologies
Historical stock prices
Current Share PriceSEK 0.059
52 Week HighSEK 0.59
52 Week LowSEK 0.044
Beta1.16
1 Month Change2.09%
3 Month Change-12.01%
1 Year Change-90.10%
3 Year Change-97.59%
5 Year Changen/a
Change since IPO-93.58%

Recent News & Updates

Recent updates

Shareholder Returns

1BDDE Medical EquipmentDE Market
7D18.6%-1.7%-0.4%
1Y-90.1%-6.8%7.9%

Return vs Industry: 1BD underperformed the German Medical Equipment industry which returned -6.8% over the past year.

Return vs Market: 1BD underperformed the German Market which returned 7.9% over the past year.

Price Volatility

Is 1BD's price volatile compared to industry and market?
1BD volatility
1BD Average Weekly Movement21.0%
Medical Equipment Industry Average Movement6.4%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 1BD's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 1BD's weekly volatility has decreased from 32% to 21% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
200635Lone Carlbomwww.bio-works.com

Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company’s products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications.

Bio-Works Technologies AB (publ) Fundamentals Summary

How do Bio-Works Technologies's earnings and revenue compare to its market cap?
1BD fundamental statistics
Market cap€6.06m
Earnings (TTM)-€3.28m
Revenue (TTM)€3.31m

1.8x

P/S Ratio

-1.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1BD income statement (TTM)
RevenueSEK 37.88m
Cost of RevenueSEK 10.16m
Gross ProfitSEK 27.72m
Other ExpensesSEK 65.24m
Earnings-SEK 37.52m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 21, 2025

Earnings per share (EPS)-0.48
Gross Margin73.18%
Net Profit Margin-99.05%
Debt/Equity Ratio0%

How did 1BD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 15:56
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bio-Works Technologies AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Klas PalinPenser Access